VAERS reports by lot

GSK Varicella/Shingles lot F93YS: VAERS reports

25 VAERS reports list lot F93YS as a GSK Varicella/Shingles vaccine, received between 2021-01-26 and 2023-02-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2130%
Dermatological (non-injection-site)1116%
Injection-site / Local reaction710%
Neurological69%
Cardiac / Cardiovascular69%
Gastrointestinal69%
Allergic / Anaphylactic57%
Musculoskeletal57%
Respiratory23%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Washington4
Pennsylvania3
Georgia2
Texas2
Minnesota2
New Jersey2
Iowa1
South Carolina1
New Mexico1
Kansas1
Missouri1
Ohio1

Reports by month received

2021-011
2021-023
2021-033
2021-044
2021-054
2021-065
2021-071
2021-081
2021-091
2021-101
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.